Written by Richard Daverman, PhD, Executive Editor, Greg B. Scott.
Click a link below to view the mailing archive as if it had been sent to you.2019-10-15 01:30CanSino to Add Shanghai Star Board IPO to Hong Kong Listing and more...2019-10-13 01:30Week in Review: Jiangsu's CTFH Signs $200 Million AI Drug Discovery Pact with Insilico2019-10-12 01:30BJ Bio Selects CMAB for CMC and Manufacturing of Cancer mAb and more...2019-10-11 01:30China Grand Pharma Pays $30 Million for Majority Stake in US-Based OncoSec and more...2019-10-10 01:30CTFH and Insilico Form $200 Million AI-Based Drug Discovery Partnership and more...2019-10-09 01:30Chipscreen Bio Partners with Novogene on Diagnostics for Cancer Drug and more...2019-10-08 01:30Beijing Gene+ Completes $28 Million B Round for Genetic Test Services2019-10-06 01:30Week in Review: Suzhou Innovent Raises $300 Million to Develop New Products2019-10-05 01:30Innovent Bio Completes $300 Million Secondary Offering in Hong Kong and more...2019-10-04 01:30Merck's Keytruda Approved as Monotherapy for Lung Cancer in China2019-10-03 01:30IASO and Innovent Approved to Start Trial of Novel CAR-T Immunotherapy2019-10-02 01:30Hrain Biotech Raises $28 Million in B Round for Immunotherapies2019-10-01 01:30CanSino Partners with Ocugen to Develop Gene Therapy Eye Treatment and more...2019-09-29 01:30Week in Review: Henlius Out-Licenses Southeast Asia Rights for PD-1 Candidate in $692 Million Deal2019-09-28 01:30Zhentai Completes Funding for Rehab Device Based on Brain-Computer Interface and more...2019-09-27 01:30Changmugu Completes $3 Million Pre-A Round for AI-Orthopedics Plans and more...2019-09-26 01:30Guanhao Bio Pays $3.1 Million to Acquire Stake in US-based ZY Therapeutics and more...2019-09-25 01:30Henlius Sells Southeast Asia Rights for PD-1 to Kalbe Genexine in $692 Million Deal and more...2019-09-24 01:30Sinopharm Invests in US Aesthetics Company; Acquires China Rights to Gel Implant and more...2019-09-22 01:30Week in Review: Investor Group Bids $4.6 Billion to Acquire China Biologic2019-09-21 01:30Investor Survey: US Leads Global Healthcare Innovation, but China to Catch Up by 2025 and more...2019-09-20 01:30China Biologic Products Receives $4.6 Billion Takeover Offer and more...2019-09-19 01:30Ping An Leads $15 Million Round in Riverain, a US Imaging Software Company and more...2019-09-18 01:30Shanghai Pharma Forms $250 Million China Antibody JV with Russia's Biocad and more...2019-09-17 01:30EdiGene Adds $11 Million to Pre-B Round for Novel Drugs Based on Gene Editing and more...2019-09-15 01:30Week in Review: Hansoh Signs $1.5 Billion Cross-Border Deal for AI-Drug Discovery with Atomwise2019-09-14 01:30Jiuzhou Pharma Pays $16 Million to Acquire US-based API CDMO and more...2019-09-13 01:30Hansoh Forms $1.5 Billion Partnership with Atomwise, an AI Drug Discovery Company and more...2019-09-12 01:30Henlius Biotech Prices Hong Kong IPO to Raise $477 Million and more...2019-09-11 01:30Insilico Closes $37 Million Series B for AI Drug Discovery from China Investors and more...2019-09-10 01:30JHL Biotech Settles IP Suit with Genentech, Discontinuing Development of Four Genentech Biosimilars and more...2019-09-08 01:30Week in Review: PAG Pays $540 Million for 58% Stake in Hisun BioRay, a China Biotech2019-09-07 01:30PAG Pays $540 Million for Majority Stake in Hisun BioRay, a Biologics Company and more...2019-09-06 01:30Beijing's Immunotech Plans to Raise up to $200 Million in Hong Kong IPO and more...2019-09-05 01:30Quan Capital Closes Second Healthcare Fund at $275 Million and more...2019-09-04 01:30Temasek, Hillhouse Pay $259 Million for 2% Stake in China's Aier Eye Hospital and more...2019-09-01 01:30Week in Review: HiFiBiO Raises $67 Million for Immune Modulator Portfolio
Please enter all required fields
Correct invalid entries
Subscription preference centerArchive Powered by FeedBlitz
Click a link below to view the mailing archive as if it had been sent to you.